Infectious Diseases – News and Features

Phase II trial in severe sepsis demonstrates the activity and tolerability of talactoferrin.

This article details how researchers from The University of Birmingham have combined molecular and phenotypic analysis of wild-type and mutant strains with computational network inference to identify molecular pathways underlying E. coli response to mild and strong acid conditions.

The research group conduct a genome-wide study to identify risk factors connecting HVC and HCC.

Mass spectrometry accelerates research to identify microbiological sources of E. coli-related illnesses and diseases.

Researchers from the University of Liverpool and the London and Liverpool Schools of Tropical Medicine have developed a new series of tetraoxane analogues and screened them for their in vitro and in vivo antimalarial activity.

Akonni Biosystems announces that the United States Patent and Trademark Office issued two patents its novel method for amplifying nucleic acids using polymerase chain reaction.

This article describes the first attempt to use the microarray as an identification tool for these food-borne viruses.

Gen-Probe to manufacture Renishaw’s RenDx molecular diagnostics kits under international standards.

Acquisition expands molecular diagnostic and infectious disease capabilities.

Research shows that nine proteins, isolated from blood, alter with age and that the profile of some of these proteins can be reversed by testosterone treatment.